Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 54,721 | 8,310 | 0 | 0 | N/A |
| Receivables | 2,266 | 1,147 | 0 | 0 | N/A |
| Other current assets | 0 | 10 | 0 | 0 | 0 |
| TOTAL | $58,992 | $10,038 | $0 | $0 | $N/A |
| Non-Current Assets | |||||
| PPE Net | 145 | 141 | N/A | N/A | N/A |
| Other Non-Current Assets | 0 | 3,210 | 0 | 0 | 0 |
| TOTAL | $145 | $3,351 | $N/A | $N/A | $N/A |
| Total Assets | $59,137 | $13,389 | $0 | $0 | $N/A |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,168 | 2,775 | 0 | 0 | 0 |
| Accrued Expenses | 1,751 | 740 | 0 | 0 | N/A |
| Other current liabilities | 1,945 | 913 | 0 | 0 | N/A |
| TOTAL | $7,864 | $4,428 | $0 | $0 | $N/A |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 10,918 | 0 | 0 | 0 |
| TOTAL | $N/A | $10,918 | $N/A | $N/A | $N/A |
| Total Liabilities | $7,864 | $15,346 | $0 | $0 | $N/A |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 22,579 | 22,036 | N/A | N/A | N/A |
| Common Shares | 22 | 1 | 0 | 0 | N/A |
| Retained earnings | -94,004 | -86,665 | 0 | 0 | N/A |
| Other shareholders' equity | -198 | 84,565 | 0 | 0 | 0 |
| TOTAL | $51,273 | $-1,957 | $0 | $0 | $N/A |
| Total Liabilities And Equity | $59,137 | $13,389 | $0 | $0 | $0 |